Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose glibenclamide in type 2 diabetes mellitus
NCT02830048Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Jul 2016
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of glibenclamide in type 2 diabetes mellitus (T2DM), sponsored by University of Oxford. Started Jul 2016; status: completed.
02
Drugs
glibenclamide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02830048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02830048.